About ABBV-744 as a potential therapeutic option for aggressive cancers
Further studies in progress recommend that ARV-825 might also be effective in maximizing the response to estrogen deprivation (aromatase inhibition), another part of normal of care in ER+ breast cancer.There might be larger treatment stress for participants During this trial when compared to their normal of treatment. Participants will show up at s